Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate
disease progression in patients coinfected with HIV. However, recent evidence suggests that …

Objectives.—To study the effect of human T-cell lymphtropic virus type I (HTLV-I) on markers
of human immunodeficiency virus (HIV) disease progression. Design.—A retrospective …

Reports indicate that there is a dissociation between markers of HIV disease progression
and clinical stage among subjects coinfected with human T-cell lymphotropic virus type I …

Human T-lymphotropic virus type II (HTLV-II) is a human retrovirus which is endemic in
Amerindian and pygmy tribes. Molecular subtypes show geographic segregation consistent …

Co-infection with HTLV-1 reaches 20% among patients infected by HIV-1 in Bahia, Brazil. To
evaluate its impact on survival, we conducted a retrospective, case–control study involving …

Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased
risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I …

Human T‐cell lymphotropic virus (HTLV) types I and II were the first discovered human
retroviruses. While HTLV‐I has been clearly associated with disease, the health implications …

Limited and contradictory information exists regarding the prognosis of HIV/HTLV-I co-
infection. Our goal was to estimate the effect of HTLV-I infection on mortality in HIV-infected …

Human T lymphotropic virus type I (HTLV-I) can increase human immunodeficiency virus
(HIV) replication in vitro, and several studies suggest that HTLV-I accelerates the …

To determine whether human T-lymphotropic virus (HTLV) type II coinfection affects
progression of human immunodeficiency virus type 1 (HIV) infection, longitudinal data on …